Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 c » 25 c (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 c » 25 c (Expand Search)
-
11181
Fundus photographs.
Published 2025“…Each subject then attempted to correctly identify lesions in a series of 12 digital color fundus photographs. …”
-
11182
CBQoL survey results<sup>‡.</sup>
Published 2025“…Each subject then attempted to correctly identify lesions in a series of 12 digital color fundus photographs. …”
-
11183
ColorDx performance by EnChroma use<sup>‡.</sup>
Published 2025“…Each subject then attempted to correctly identify lesions in a series of 12 digital color fundus photographs. …”
-
11184
-
11185
-
11186
-
11187
-
11188
DataSheet2_Treatment of wild-type mice with 2,3-butanediol, a urinary biomarker of Fmo5−/− mice, decreases plasma cholesterol and epididymal fat deposition.pdf
Published 2022“…Our results indicate a microbial contribution to the phenotypic characteristic of Fmo5<sup>−/−</sup> mice of decreased plasma cholesterol and identify 2,3-butanediol as a potential agent for lowering plasma cholesterol.…”
-
11189
DataSheet1_Treatment of wild-type mice with 2,3-butanediol, a urinary biomarker of Fmo5−/− mice, decreases plasma cholesterol and epididymal fat deposition.PDF
Published 2022“…Our results indicate a microbial contribution to the phenotypic characteristic of Fmo5<sup>−/−</sup> mice of decreased plasma cholesterol and identify 2,3-butanediol as a potential agent for lowering plasma cholesterol.…”
-
11190
-
11191
-
11192
-
11193
-
11194
-
11195
-
11196
-
11197
-
11198
Supplemental data 3.
Published 2025“…Akt3 null hearts at midgestation (E14.5), a stage in which proliferation is occurring, have decreased Aurora B expression, increased CRM-1 expression, decreased proliferation, and increased apoptosis. …”
-
11199
The enhancer of <i>Furin</i> M10 is repressed by NKX2-5.
Published 2019“…(C) Electrophoretic mobility shift assay (EMSA) showing that NKX2-5 binds its motif (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0212992#sec002" target="_blank">methods</a>) in the M10 probe (black arrowhead). …”
-
11200